WebbOur technology is highlighted in our most recent publication "Precision-activated T-cell engagers targeting HER2 or EGFR and CD3 mitigate on-target, off-tumor… WebbDuring my graduate studies in Madrid, Spain, I gained multiple years of experience working with small molecule development for delivering anti-HIV nucleic acid therapies to HIV-infected lymphocytes. A large part of the project focused on characterizing the size, physiochemical properties and cellular uptake of nanoparticles.
Table 1: Current viral measurements and strategies to estimate …
WebbSheryl Jiang’s Post Sheryl Jiang A Headhunter 1w WebbNext in series, our publication about engineering #cart #celltherapy into an #serologytest #syntheticbiology platform for #infectiousdiseases and its… cvf050r1
High CD45 expression of CD8+ and CD4+ T cells correlates with …
Webb9 apr. 2024 · HIV-1 is a complex retrovirus that is adapted to replicate in cells of the immune system. To do so, HIV-1, like other viruses, developed strategies to use several cellular processes to its advantage, but had also to come to terms with an arsenal of cellular innate defense proteins, or antiviral factors, that target more or less efficiently, … WebbHowever, how myeloid cells contribute to the size of the HIV reservoir and what impact they have on rebound after treatment interruption remain unclear. Here we report the development of a human monocyte-derived macrophage quantitative viral outgrowth assay (MDM-QVOA) and highly sensitive T cell detection assays to confirm purity. WebbiScience, APR 2024 #Olink targeted plasma #proteomics identifies MICA and IL1R1 proteins associated with #HIV-1 reservoir size! Given the well-established role… cvf02-02b